Among over 125,000 patients, 53.6% discontinued their GLP-1 receptor agonist by 1 year, and these rates were significantly ...

A new poll from The Associated Press-NORC Center for Public Affairs Research shows about half of U.S. adults believe it is a good thing for adults to use weight-loss drugs like Ozempic, Wegovy and ...

While Hannah hasn't found the drug to be useful for weight loss, six months on, she's more than willing to keep paying the ...

Weight-loss drugs are transforming health care and Wall Street, but exciting prospects don’t necessarily mean a company is a good investment.

The miscue was one of several frustrating components of the loss, including three turnovers (notably a fumbled opening kickoff), and eight penalties for 85 yards. Slaton's wasn't even the first ...

Wegovy is a GLP-1 agonist containing semaglutide, the same active ingredient as Ozempic. While both medications share this ...

Find out all you need to know about Ozempic and other weight loss drugs, including the dangers and side effects ...

If that person loses 20 kilograms (44 pounds) in one year while taking a GLP-1R agonist — which is not unreasonable while ...

TransCon CNP matches BioMarin's Voxzogo for achondroplasia with plans for regulatory filings in 2025, showing potential for ...

Hers shares information about the average weight for women in the U.S., what women believe the ideal weight is, and the ...

Recent findings indicate that widely used weight-loss medications might lead to muscle loss, including vital heart muscle, ...